190 related articles for article (PubMed ID: 9474345)
1. The development of cast nephropathy in multiple myeloma.
Iggo N; Winearls CG; Davies DR
QJM; 1997 Nov; 90(11):653-6. PubMed ID: 9474345
[No Abstract] [Full Text] [Related]
2. The kidney in plasma cell dyscrasias: Bence-Jones cast nephropathy and light chain deposit disease.
Cohen AH
Am J Kidney Dis; 1998 Sep; 32(3):529-32. PubMed ID: 9740176
[No Abstract] [Full Text] [Related]
3. Nephrotoxic potential of Bence Jones proteins.
Solomon A; Weiss DT; Kattine AA
N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
[TBL] [Abstract][Full Text] [Related]
4. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
Iványi B
Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
[TBL] [Abstract][Full Text] [Related]
5. Acute light chain tubulopathy in myeloma.
Yong JL; Killingsworth MC
Pathology; 2009; 41(3):300-2. PubMed ID: 19291548
[No Abstract] [Full Text] [Related]
6. [A case of multiple myeloma with alternating paraprotein; non-secretory myeloma (IgG-kappa) converted to nonproducing myeloma, and finally to secretory myeloma (BJ-lambda) (author's transl)].
Fujii H; Kanoh T
Nihon Naika Gakkai Zasshi; 1981 Nov; 70(11):1553-61. PubMed ID: 6801164
[No Abstract] [Full Text] [Related]
7. [Early treatment of a Bence-Jones-kappa-light-chain-paraproteinemia].
Bethge WA; Einsele H
Internist (Berl); 2004 Apr; 45(4):466-7. PubMed ID: 15152615
[No Abstract] [Full Text] [Related]
8. Myeloma kidney cast nephropathy in a rat model of multiple myeloma.
Smolens P; Venkatachalam M; Stein JH
Kidney Int; 1983 Aug; 24(2):192-204. PubMed ID: 6415338
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of active-transport sodium-potassium-A.T.P.ase by myeloma protein.
McGeoch J; Falconer Smith J; Ledingham J; Ross B
Lancet; 1978 Jul; 2(8079):17-8. PubMed ID: 78213
[TBL] [Abstract][Full Text] [Related]
10. Renal complications of B-cell dyscrasias.
Gallo G
N Engl J Med; 1991 Jun; 324(26):1889-90. PubMed ID: 1904135
[No Abstract] [Full Text] [Related]
11. Adult Fanconi syndrome secondary to kappa-light chain myeloma: improvement of tubular functions after treatment for myeloma.
Uchida S; Matsuda O; Yokota T; Takemura T; Ando R; Kanemitsu H; Hamaguchi H; Miyake S; Marumo F
Nephron; 1990; 55(3):332-5. PubMed ID: 2115147
[TBL] [Abstract][Full Text] [Related]
12. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
[TBL] [Abstract][Full Text] [Related]
13. Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma.
Bouchet A; Teuma C; Nouvier M; Rousset P; Javaugue V; Lazareth A; Lombard C; Isaac S; Fouque D
Am J Kidney Dis; 2019 Nov; 74(5):700-702. PubMed ID: 31155325
[TBL] [Abstract][Full Text] [Related]
14. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
Finkel KW; Cohen EP; Shirali A; Abudayyeh A;
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2273-2279. PubMed ID: 27526708
[TBL] [Abstract][Full Text] [Related]
15. Clearances of Bence-Jones proteins during peritoneal dialysis or plasmapheresis in myelomatosis associated with renal failure.
Sølling K; Sølling J
Contrib Nephrol; 1988; 68():259-62. PubMed ID: 3234000
[No Abstract] [Full Text] [Related]
16. Catalytic activities and functional effects of Bence Jones proteins.
Sinohara H; Matsuura K
Chem Immunol; 2000; 77():89-101. PubMed ID: 11706708
[No Abstract] [Full Text] [Related]
17. Serum test for assessment of patients with Bence Jones myeloma.
Bradwell AR; Carr-Smith HD; Mead GP; Harvey TC; Drayson MT
Lancet; 2003 Feb; 361(9356):489-91. PubMed ID: 12583950
[TBL] [Abstract][Full Text] [Related]
18. [Renal failure].
Arai T; Matsuzaki K
Nihon Rinsho; 1995 Mar; 53(3):703-9. PubMed ID: 7699909
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.
Zand L; Nasr SH; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Kumar S; Kyle RA; Fervenza FC; Sethi S; Dingli D; Rajkumar SV; Kapoor P; McCurdy A; Leung N
Leuk Lymphoma; 2015; 56(12):3357-64. PubMed ID: 25860232
[TBL] [Abstract][Full Text] [Related]
20. [Renal involvement in multiple myeloma. Physiopathology and therapy].
Fiorini F; Napoli S; Giordano L; Castelluccio A
Minerva Urol Nefrol; 1995 Sep; 47(3):125-31. PubMed ID: 8815549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
